Aprea Executives Stack Up Stakes: CFO Buys 5,700 Shares, 5,700 Warrants in Low‑Priced Surge
Insider buying surge at Aprea Therapeutics: CFO John Hamill buys shares and warrants at $0.89, signaling management confidence amid an 80% slump.
3 minutes to read

